WEREWOLF THERAPEUTICS
1.9600
26-November-24 16:45:00
15 minutes delayed
Stocks
-0.0400
-2.00%
Today's range
1.9050 - 2.0400
ISIN
N/A
Source
NASDAQ
-
18 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update
12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Its Addition to the Russell 2000® Index
24 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Chulani Karunatilake, Ph.D. as Chief Technology Officer
15 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports First Quarter 2021 Financial Results
10 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors
28 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Jefferies Virtual Healthcare Conference 2021
27 May 2021 07:30:00 By Nasdaq GlobeNewswire